Question 1

What is Protara Therapeutics' focus?

Accepted Answer

Protara Therapeutics is focused on developing transformative therapies, with a particular emphasis on their lead investigational cell therapy, TARA-002, and their investigational phospholipid substrate replacement therapy, IV Choline Chloride.

Question 2

What is TARA-002?

Accepted Answer

TARA-002 is Protara Therapeutics' lead investigational cell therapy, which is based on the broad immunopotentiator OK-432. The company is evaluating TARA-002 for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs) in the U.S.

Question 3

What is IV Choline Chloride?

Accepted Answer

IV Choline Chloride is an investigational phospholipid substrate replacement therapy that Protara Therapeutics is developing for patients on parenteral nutrition (PN). Approximately 80% of PN patients are choline deficient and have some degree of liver damage, and IV Choline Chloride has the potential to become the first FDA-approved IV choline formulation for PN patients.

Question 4

Where is Protara Therapeutics located?

Accepted Answer

Protara Therapeutics is headquartered in New York, NY, with their office located at 345 Park Avenue South, 3rd floor, New York, NY 10010.

Question 5

How can I contact Protara Therapeutics?

Accepted Answer

You can contact Protara Therapeutics by phone at +1 646-844-0337 or by email at info@protaratx.com. The company also provides a contact form on their website for inquiries.

Protara Therapeutics

Company Overview

Company Name

Address

Website

Phone

Employees

About Protara Therapeutics

Frequently Asked Questions about Protara Therapeutics

What is Protara Therapeutics' focus?

What is TARA-002?

What is IV Choline Chloride?

Where is Protara Therapeutics located?

How can I contact Protara Therapeutics?

Technologies Used

Key Decision Makers